Showing results (131-140 of 206) with videos related to

Sort By:
Pageof 21
Blood Cancer Discovery|April 19, 2026
MYST acetyltransferases interact with SETBP1 and are a targetable therapeutic vulnerability in SETBP1-mutant leukemiaHanqian L Carlson, Thai T Nguyen, Samantha Tauchmann, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 19, 2020
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 AbnormalitiesDavid A Sallman, John Barnard, Najla H Al Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2016
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)Eric Padron, Amy Dezern, Marcio Andrade-Campos, et al.
JCI Insight|July 5, 2022
Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromesAmy F McLemore, Hsin-An Hou, Benjamin S Meyer, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
Cancer|September 15, 2022
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutationsSomedeb Ball, Todd C Knepper, Yehuda E Deutsch, et al.
The Journal of Clinical Investigation|October 17, 2023
A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in miceAdhithi Rajagopalan, Yubin Feng, Meher B Gayatri, et al.
Blood Advances|May 5, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national studyGregory A Abel, Donnie Hebert, Cecilia Lee, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
Pageof 21